Ann: Change of Director's Interest Notice, page-42

Doctors without border withdraw their field testing pre regulatory approval due to funding (who knows they might be interested in using ResAppDx after the pilot evaluation done in Africa), the German Hospital evaluation pilot got ethical approval from their medical board just before COVID-19 hit and is still going a head, WASH project ended and similarly Sanofi didn't want to exercise exclusivity for new DTC product at the end of the project.